Scientific Advisory Board
Professor Dr Sjoerd van der Burg
Chair
Since beginning my research career in 1995, I have focused on understanding the immune response to cancer and translating that knowledge into effective therapies. Immunotherapy has transformed treatment prospects for several cancers. I want to use my expertise to help identify the research most likely to improve treatment for pancreatic cancer.
Ada Kruisbeek
Member
Much of my scientific career has focused on strengthening the immune response to cancer. Immunotherapy has greatly expanded treatment options, and I am pleased to contribute my experience and expertise to pancreatic cancer research through both requested and independent advice.
Professor Dr Maarten Bijlsma
Member
As Professor of Experimental Gastrointestinal Oncology and Scientific Director of Cancer Center Amsterdam, I study the biology of aggressive gastrointestinal tumours, particularly pancreatic cancer. My laboratory investigates how the tumour stroma — especially activated connective-tissue cells — drives resistance to therapy and where new therapeutic opportunities may lie. I aim to translate fundamental cancer research into better treatments for patients as quickly as possible.
Professor Dr Hanneke Wilmink
Member
As a medical oncologist at Amsterdam UMC, I specialise in gastrointestinal cancers, with a particular focus on pancreatic cancer and metabolism. My central aim is to improve patients’ quality of life and survival through excellent care, innovative clinical and translational research, and high-quality education.